about
Vascular access for extracorporeal life support: tips and tricksShould cystic fibrosis patients infected with Burkholderia cepacia complex be listed for lung transplantation?The European educational platform on thoracic surgeryPrognostic value of the KRAS G12V mutation in 841 surgically resected Caucasian lung adenocarcinoma casesN2-IIIA non-small cell lung cancer: a plea for surgery!Superior sulcus non small cell lung carcinoma: retrospective analysis of 42 patientsThe AESOP (adenopathy and extensive skin patch overlying a plasmacytoma) syndrome: report of 4 cases of a new syndrome revealing POEMS (polyneuropathy, organomegaly, endocrinopathy, monoclonal protein, and skin changes) syndrome at a curable stage.KRAS and BRAF mutations are prognostic biomarkers in patients undergoing lung metastasectomy of colorectal cancer.Does the use of extended criteria donors influence early and long-term results of lung transplantation?Manubriosternal disjunction a new approach for surgical repair.Re-anastomosis of the anomalous segmental pulmonary vein during inferior bilobectomy.Are daily routine chest radiographs necessary after pulmonary surgery in adult patients?Video-assisted thoracoscopic lobectomy: which is the learning curve of an experienced consultant?Summary report of the Standards, Options and Recommendations for the management of patients with non-small-cell lung carcinoma (2000).Endogenous Intoxication and Saliva Lipid Peroxidation in Patients with Lung Cancer.Thoracic oncology HERMES: European curriculum recommendations for training in thoracic oncology.Does nodal status influence survival? Results of a 19-year systematic lymphadenectomy experience during lung metastasectomy of colorectal cancer.KRAS exon 2 codon 13 mutation is associated with a better prognosis than codon 12 mutation following lung metastasectomy in colorectal cancer.Surgery for the sequelae of postprimary tuberculosis.Is radiofrequency ablation or stereotactic ablative radiotherapy the best treatment for radically treatable primary lung cancer unfit for surgery?Should mediastinal lymphadenectomy be performed during lung metastasectomy of renal cell carcinoma?Should we perform bilateral-lung or heart–lung transplantation for patients with pulmonary hypertension?The European initiative for quality management in lung cancer care.Primary lung cancer in lung transplant recipients.Surgery for huge mediastinal tumors.Multidisciplinary tumor board decision-making for postoperative radiotherapy in thymic epithelial tumors: Insights from the RYTHMIC prospective cohort.Low Accuracy of Computed Tomography and Positron Emission Tomography to Detect Lung and Lymph Node Metastases of Colorectal Cancer.Thoracic surgery training in Europe-the perspective of a trainee.Superior sulcus non-small cell lung carcinoma: A comparison of IMRT and 3D-RT dosimetry.Impact of EGFR mutations and KRAS amino acid substitution on the response to radiotherapy for brain metastasis of non-small-cell lung cancer.Perioperative bevacizumab improves survival following lung metastasectomy for colorectal cancer in patients harbouring v-Ki-ras2 Kirsten rat sarcoma viral oncogene homologue exon 2 codon 12 mutations†.Extracorporeal Membrane Oxygenation for Acute Respiratory Distress Syndrome After Pneumonectomy.Current practices in the management of malignant pleural effusions: a survey among members of the European Society of Thoracic Surgeons.Bronchial complications after lung transplantation are associated with primary lung graft dysfunction and surgical technique.Epidermal growth factor receptor and v-Ki-ras2 Kirsten rat sarcoma viral oncogen homologue-specific amino acid substitutions are associated with different histopathological prognostic factors in resected non-small-cell lung cancer.Specific KRAS amino acid substitutions and EGFR mutations predict site-specific recurrence and metastasis following non-small-cell lung cancer surgery.Microscopic N2 disease exhibits a better prognosis in resected non-small-cell lung cancer.MET gene copy number in non-small cell lung cancer: molecular analysis in a targeted tyrosine kinase inhibitor naïve cohort.External validation of a risk score in the prediction of the mortality after esophagectomy for cancer.Epidermal growth factor receptor mutations are linked to skip N2 lymph node metastasis in resected non-small-cell lung cancer adenocarcinomas.
P50
Q26748358-2748A35A-10C9-4E72-A482-2D60D05A598EQ26991550-B92148E4-B3CB-468C-994E-5464DAFDF1DDQ27016572-4456D5BB-A928-4169-88D5-92E750F54383Q27853213-BEF8A0D2-9D96-478F-93AD-A1D95CDA2CB3Q28069001-2293D049-2029-4D30-B141-DE2C376CD391Q34720546-61A5A600-D7D7-4A9F-891B-4E144799D632Q35052158-0D5DAC0D-5C54-492E-9CA2-D7B8416DAB38Q35098287-318B81EA-933F-4547-B354-A3AA739860ADQ35758387-5878E499-6041-418B-9540-5DF82638C080Q35967128-89755AB6-0243-4141-97B5-2D270C9E47D6Q36097543-1B9AA916-8E1A-47F1-A24E-F3546EA6FA89Q37312372-CAAF0164-FC67-4317-8642-CE603359C52EQ37329470-6E5FF6F8-22F7-4BFA-96D0-541559974BF8Q37365195-C4C0FA10-C1C4-4D43-BAA3-869D34A002C6Q37539544-B403585A-C1E3-42C1-A0E7-7ABCD7FE3D86Q37631983-168987F2-C62C-4B50-8A50-B0D04A37BB29Q37642752-0FD0386C-AD53-4DC2-A521-A24C5E866ED9Q37709323-AB76ACD6-79A6-481D-A3B5-F9ECF9849A8EQ38025792-2B70CB29-BFFC-4BD7-AAD5-8ED65F987489Q38051243-663195BC-63C5-480A-9CD5-A308AA98FFBDQ38071490-66D6DED9-706B-4ABA-AEA3-5EFB908D3DA3Q38098083-98FAFC7A-0AA3-4336-8070-700F10E5FF1AQ38198586-E8906EE8-A3C4-49B4-8A4B-CC2FD47C7BB9Q38214216-6A4204FE-DD0B-4FDF-A1A2-7B6A3D922ECDQ38526983-259ABD38-4B8A-4DB9-BBB0-543784C43E0FQ38642504-C475524A-7A7C-4B4F-AAE2-4B8A0071C8E1Q38651094-80A55805-0327-41C0-B3ED-C6D8DE997498Q38690424-CF282071-5562-45C2-B7C7-81580895EF9AQ38834703-2C35B8FC-C959-4ECC-B248-2533A7AC6B09Q38937520-FD986CA5-69D4-4CAB-A7EA-7DEB72395330Q38967826-17B18271-0421-4651-B12E-356A352285D7Q38974726-AB53F047-4826-4258-8955-20683EF88F8DQ39045597-ADFEC1B9-BB0D-4D57-9DF2-4575723DE314Q39400839-71C25F96-FDB8-4F7D-8860-9B644A719FC9Q39484881-6676EB08-3E66-4369-A9DD-AD858D359E9EQ39660590-3059C9D3-B4D4-4B96-A97D-AED7839B2127Q39964574-3CFC9391-A9A7-4287-9BC4-AB604C2127FDQ40108065-4551FCF9-943B-4A3B-BDA9-96A7204FCA51Q40145952-1A661DF3-873C-49BB-8B0B-24BDBDFE7D45Q41010403-7E6E994E-6EF0-4D6D-88C1-4CFC5DCF7CA1
P50
description
researcher ORCID ID = 0000-0002-6942-6996
@en
wetenschapper
@nl
name
Gilbert Massard
@ast
Gilbert Massard
@en
Gilbert Massard
@es
Gilbert Massard
@nl
type
label
Gilbert Massard
@ast
Gilbert Massard
@en
Gilbert Massard
@es
Gilbert Massard
@nl
prefLabel
Gilbert Massard
@ast
Gilbert Massard
@en
Gilbert Massard
@es
Gilbert Massard
@nl
P106
P1153
7006458352
P31
P496
0000-0002-6942-6996